Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

40.11. Analysis.

40.11

Comparison 40 Adverse events within 12 months: etanercept + disease‐modifying anti‐rheumatic drug (DMARD) vs. DMARD, Outcome 11 Interstitial lung disease.